2 Discounted Dividend Stocks for Your RRSP

Build a nest egg in your RRSP today without the hindrance of taxes. Consider quality and discounted dividend stocks such as Brookfield Property Partners LP (TSX:BPY.UN)(NYSE:BPY) and another company today.

| More on:
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Registered Retirement Savings Accounts (RRSPs) are great for investing for your retirement because contributing to RRSPs reduces your income taxes for the tax year, so the higher tax bracket you’re at, the more taxes you’ll save when you contribute to your RRSP. Furthermore, what’s earned inside remains tax free until it’s withdrawn.

Here are two quality discounted dividend companies to consider for your RRSP.

Brookfield Property Partners LP (TSX:BPY.UN)(NYSE:BPY) owns, operates, and invests in quality commercial properties around the world. Its portfolio consists primarily of core office and retail assets (about 85%) and opportunistic assets (about 15%).

It targets total returns of 12-15% for its core portfolio and total returns of 20% for its opportunistic portfolio, which consists of assets across the multifamily, industrial, hospitality, triple net lease, and self-storage sectors.

Brookfield Property’s 4.7% yield is supported by stable cash flows generated by its diversified portfolio across the United States, Canada, Brazil, the United Kingdom, Europe, Australia, China, and India.

At about $31 per unit, Brookfield Property trades at a discount of roughly 20% from its IFRS value. Additionally, the company aims to increase its funds from operations per unit by 8-11% per year, while increasing its distribution by 5-8% per year. So, Brookfield Property is a good candidate for both total return and income investors.

(* – the original version of this post provided some potentially misleading tax related information which has been removed)

Gilead Sciences, Inc. (NASDAQ:GILD) develops and commercializes therapies to treat life-threatening diseases such as HIV, Hepatitis B, and Hepatitis C. Gilead Sciences has operations in more than 30 countries around the world.

At US$85.50 per share, Gilead Sciences trades at a cheap multiple of seven. The main reason it’s trading at a big discount is because the market can’t see clear growth in the near term. For example, its EPS are estimated to grow about 3% per year in the next three to five years.

That said, investors who have a long-term view can consider Gilead Sciences’s quality shares today because they’re cheap. Gilead Sciences has a top-notch S&P credit rating of A.

Other factors that make Gilead Sciences attractive include the fact that it started paying a dividend last year and its payout ratio is very low. This year it hiked its dividend by 9.3%.

Even if it decides to increase its dividend by 9% every year through 2020, its payout ratio would still be below 19%, assuming EPS growth of 3% every year.

In any case, with a payout ratio of about 16%, investors can expect Gilead Sciences to grow its dividend for many years to come.

Conclusion

Investors can consider Brookfield Property and Gilead Sciences for a better chance of higher returns than the market due to their discounted shares and the likelihood of growing income. Brookfield Property also offers a decent 4.7% yield to start.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Kay Ng owns shares of Brookfield Property Partners and Gilead Sciences. The Motley Fool owns shares of Gilead Sciences. Gilead Sciences is a recommendation of Stock Advisor Canada.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »